International Journal of

Diabetes and Clinical ResearchISSN: 2377-3634

Archive

 Open Access DOI:10.23937/2377-3634/1410050

A Comprehensive Analysis of the Financial Burden of Diabetes Mellitus at Rafik Hariri University Hospital: The Economic Implications from the Public Sector Perspective in Lebanon

Akram Echtay, Rita Nemr, Maya Chehabeddine, Ramona Abi Gerges, Wadih Baajour, Nader Kakoun, Marwan Charif and Selim Jambart

Article Type: Research Article | First Published: December 18, 2015

Diabetes Mellitus (DM) is a pandemic health problem with an unprecedented number of patients reaching hundreds of millions, and characterized by the vascular complications and premature mortality incurring a high cost of management. The aim of this study was to assess the economic burden of DM management and its complications in Beirut through comparing the hospitalization cost for patients with DM to that of patients not suffering from DM....

 Open Access DOI:10.23937/2377-3634/1410049

Evidence Based Prevention of Type 2 Diabetes: Role of Lifestyle Intervention as Compared to Pharmacological Agents

V. Naik, R. Dave, J. W. Stephens and J.S. Davies

Article Type: Review Article | First Published: December 08, 2015

Type 2 Diabetes Mellitus (T2DM) is one of the most costly and burdensome of chronic diseases and is a global epidemic. Estimates by the International Diabetes Federation indicate that 387 million people have diabetes, and that this figure is expected to rise to 592 million by 2035 with an additional 175 million cases currently undiagnosed. Individuals with T2DM are at a significantly higher risk of co-morbidities particularly cardiovascular disease (CVD). Additionally, pre-diabetes independently...

 Open Access DOI:10.23937/2377-3634/1410048

Why, When and How We Propose Withdrawal Insulin Treatment in Type 2 Insulin Resistant Diabetes

Andreu Nubiola, Imma Remolins and Miquel Nubiola

Article Type: Review Article | First Published: November 17, 2015

Insulin treatment is the choice in insulinopenic diabetic patients, in order to prevent or delay microvascular lesions, related to hyperglycaemia. However in insulin resistant type 2 diabetes, the improvement in glycaemic control with insulin, is not without side effects, especially weight gain and hypoglycaemia. Many retrospective or case-control studies of insulin treatment have reported a higher prevalence of CVD in insulin-treated patients. However, many of these patients started insulin the...

 Open Access DOI:10.23937/2377-3634/1410047

Glucose Tolerance is Improved Following Surgery for Silent Somatotroph Adenoma

Aika Miya, Akinobu Nakamura, Hideaki Miyoshi, Hiraku Kameda, Hiroshi Nomoto, So Nagai, Yuko Omori, Kanako C. Hatanaka, Hiroyuki Kobayashi, Chikara Shimizu, and Tatsuya Atsumi

Article Type: Case Report | First Published: November 05, 2015

Although the excessive secretion of GH leads to insulin resistance enhancement, the involvement of a silent somatotroph adenoma in abnormal glucose tolerance has not been elucidated. A 50 - year-old man was admitted with a headache and bitemporal hemianopia caused by a pituitary macroadenoma. He had no physical signs and symptoms of acromegaly nor hypopituitarism, and his base-line serum levels of GH and insulin - like growth factor-1 (IGF-1) were normal. However, a 75 - g oral glucose tolerance...

Volume 2
Issue 6